Skip to content

Effect of flaxseed oil on pre-diabetes control

The effects of flaxseed oil supplementation in Glycemic control and body composition on overweight pre-diabetes patients

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20120913010826N27
Enrollment
40
Registered
2018-02-07
Start date
2017-11-06
Completion date
Unknown
Last updated
2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prediabet. Impaired glucose tolerance (oral)

Interventions

Intervention 1: Intervention group: To the intervention group, for 2 weeks, 2 capsules of 1000 mg of linseed oil will be given to the Barij Essen Pharmaceutical Company in Kashan. Given the length of

Sponsors

Yazd University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Fasting blood glucose should be between 100 and 125 mg / dL The body mass index is between 25 and 29.9.

Exclusion criteria

Exclusion criteria: Receive oral hypoglycemic drugs and insulin injections Cure for any type of acute and chronic disease Any kind of allergy or intolerance to your seed oil smoking Having severe activity and unusual diet Women having a monthly cycle for at least 6 months Use of anti-inflammatory drugs Having regular consumption of your seed, flaxseed oil, fish oil, fish and soy supplement

Design outcomes

Primary

MeasureTime frame
Fasting insulin. Timepoint: Before the intervention and 14 weeks after the intervention. Method of measurement: Blood test, µU/ml.

Secondary

MeasureTime frame
Weight. Timepoint: Before the intervention and 14 weeks after the intervention. Method of measurement: With scale.;Fbs. Timepoint: Before the intervention and the end of the week 14. Method of measurement: Blood test? mg/dl.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Azadeh Nadjarzadeh

Yazd University of Medical Sciences

azadnajarzadeh@ssu.ac.ir+98 35382091001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026